Glenmark, Alembic Pharma, Sun Pharma shares slip up to 1.5% on product recalls after USFDA action
The recent regulatory-mandated product withdrawals by three pharmaceutical firms led to a modest decrease in their stock prices, reflecting investor c...
Read Full Article →